Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stock Scan November 2017: Generics get volatile

Executive Summary

Generic drug producers endured very mixed fortunes on the world's stock markets, with firms ending November at opposite ends of Scrip's Stock Scan monthly league table.

Advertisement

Related Content

As Regeneron Worries Rise On Eylea Combo Failure, Eyes Turn To PANORAMA
First ‘Digital Medicine’ Approved, Slow Rollout Planned
Payer Pushback Underpins Mallinckrodt's Disappointing Q3 Results
Stock Scan October: Generics Pull Pharma Down
Quarterly Reporting: Investor Reality Check Or Pharma Communication Gap?
Generic Price-Fixing Lawsuit Grows As More Companies, Two Executives Named Defendants

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100007

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel